Stressgen Biotechnologies Corp (SSB-T) Stock Predictions - Stockchase
WATCH LIST
23
Stressgen Biotechnologies Corp (SSB-T)

ON STOCKCHASE SINCE Oct 2000

Working on cure for human pappiloma virus

biotechnology/pharmaceutical

Stressgen Biotechnologies...

SSB-T

0 watching          
Join the Discussion

Stressgen Biotechnologies Corp (SSB-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about SSB-T



  • All
  • Filtered
Signal Opinion Expert
DON'T BUY
A lottery ticket! The company has gone into orphan status. Have disappointed investors many, many times. They keep needing money. Very risky.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A lottery ticket! The company has gone into orphan status. Have disappointed investors many, many times. They keep needing money. Very risky.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$0.370
Owned Owned
No

DON'T BUY
Trying to raise $50 million which is equivalent/more than their entire market cap.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Trying to raise $50 million which is equivalent/more than their entire market cap.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Duncan Stewart

Director o, DSAM Consulting...

Price Price
$0.440
Owned Owned
No

PAST TOP PICK
(A Top Pick June 14/04. Down 56%.) They continue to lose money. They'll have to get something through their pipeline quickly that deals with cancer. Doesn't look good.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick June 14/04. Down 56%.) They continue to lose money. They'll have to get something through their pipeline quickly that deals with cancer. Doesn't look good.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Benj Gallander

President, Contra the Heard Inv...

Price Price
$0.455
Owned Owned
No

TOP PICK
Holds this stock personally. Risky could double.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Holds this stock personally. Risky could double.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Benj Gallander

President, Contra the Heard Inv...

Price Price
$1.060
Owned Owned
Yes

VAGUE
A field that you have to be really wary of. Many of them have a very high burn rate. Although their trials were fast tracked, this does not necessarily mean continued success.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A field that you have to be really wary of. Many of them have a very high burn rate. Although their trials were fast tracked, this does not necessarily mean continued success.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Benj Gallander

President, Contra the Heard Inv...

Price Price
$1.930
Owned Owned
No

DON'T BUY
Have restructured and will need more money.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Have restructured and will need more money.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$2.130
Owned Owned
No

BUY
Very volatile. Developing a product for HBV (a sexually transmitted disease), which has a large market. In phase two. Has a partnership with Roach and has enough cash to probably last into 2005.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Very volatile. Developing a product for HBV (a sexually transmitted disease), which has a large market. In phase two. Has a partnership with Roach and has enough cash to probably last into 2005.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
John Sinkins, C

Senior Por, Sentry Select Capita...

Price Price
$2.040
Owned Owned
No

DON'T BUY
On their watch list. Lost a lot of maney last year.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
On their watch list. Lost a lot of maney last year.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Benj Gallander

President, Contra the Heard Inv...

Price Price
$1.710
Owned Owned
No

BUY on WEAKNESS
A speculative stock. Has to move through the regulatory gateway. Meets a lot of technical resistance at the $1.81 level. Try to pick up near its support level of $1.25.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
A speculative stock. Has to move through the regulatory gateway. Meets a lot of technical resistance at the $1.81 level. Try to pick up near its support level of $1.25.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Lou Schizas

Business E, Market Call...

Price Price
$1.780
Owned Owned
Unknown

BUY
They are far enough into their trials that investors are now paying more attention. Relatively cheap. Management is OK.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
They are far enough into their trials that investors are now paying more attention. Relatively cheap. Management is OK.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$1.900
Owned Owned
Unknown

BUY
Outlook is quite good and the price is at a good level.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Outlook is quite good and the price is at a good level.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Mike Weir

Managing D, Guardian Capital...

Price Price
$2.450
Owned Owned
Unknown

BUY
At a good level. Has mad a good agreement with a large pharmaceutical.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
At a good level. Has mad a good agreement with a large pharmaceutical.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Mike Weir

Managing D, Guardian Capital...

Price Price
$3.250
Owned Owned
Unknown

WEAK BUY
In the final stage of their clinical trials. Will be a couple of years before you know if the product works.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
In the final stage of their clinical trials. Will be a couple of years before you know if the product works.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Bruce Cooper

Portfolio , T.D. Asset...

Price Price
$4.500
Owned Owned
Unknown

WEAK BUY
Well along on the approval line. Product seems to be good. The sector is suffering. A higher risk.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Well along on the approval line. Product seems to be good. The sector is suffering. A higher risk.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Bruce Cooper

Portfolio , T.D. Asset...

Price Price
$3.530
Owned Owned
Unknown

WAIT
Fairly risky, but a good risk/reward ratio. In phase 3 trials. Could double if they get into a good partnership.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Fairly risky, but a good risk/reward ratio. In phase 3 trials. Could double if they get into a good partnership.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Bruce Cooper

Portfolio , T.D. Asset...

Price Price
$5.500
Owned Owned
Unknown

Showing 1 to 15 of 23 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days